PDYN and psychiatric disorder: Dysregulation of the dynorphin/KOP system may contribute to behavioral abnormalities that are commonly shared by psychiatric disorders (i.e. decreased motivation and negative affect) [44], while non-opioid effects of dynorphins on NMDA or AMPA receptors could result in apoptosis and neurodegeneration [45].